• 應用文獻

內分泌

從低劑量噻嗪類利尿劑轉換成SGLT2抑制劑(第2型鈉-葡萄糖轉運蛋白抑制劑)改善了各種代謝參數，而不影響第二型糖尿病和高血壓患者的血壓。

Switching from low-dose thiazide diuretics to sodium-glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension. J Diabetes Investig 2017.

2017 | InBody770 I Division of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Kurashiki, Okayama, Japan

Tomohiko Kimura, Junpei Sanada, Masashi Shimoda, Hidenori Hirukawa, Yoshiro Fushimi, Momoyo Nishioka, Tomoe Kinoshita, Seizo Okauchi, Atsushi Obata, Kenji Kohara, Fuminori Tatsumi, Shinji Kamei, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto.

SGLT2抑制劑(第2型鈉-葡萄糖轉運蛋白抑制劑)Dapagliflozin可改善糖尿病腎病患者的細胞外液體積的增加。

2 Inhibition with Dapagliflozin Ameliorates Extracellular Volume Expansion in Diabetic Kidney Disease Patients. POJ Diabetes Obes.1 (1): 1-8 (2017)

2017 | InBody S10 I Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan

Takahiro Masuda, Ken Ohara, Takuya Murakami, Toshimi Imai, Saki Nakagawa, Mari Okada, Atsushi Miki, Akihiro Myoga, Akira Onishi, Chuji Sekiguchi, Yasuharu Miyazawa, Tetsu Akimoto, Osamu Saito, Shigeaki Muto, and Daisuke Nagata. Sodium-Glucose cotransporter.

一項前瞻性，隨機，臨床研究比較抗甲狀腺藥物與放射性碘治療：抗甲狀腺治療對骨骼和身體組成成分的影響。

Effect of Antithyroid Therapies on Bone and Body Composition: A Prospective, Randomized, Clinical Study Comparing Antithyroid Drugs with Radioiodine Therapy. Indian J Endocr Metab 2017;21:531-4.

2017 | InBody720 I Department of Endocrinology, Army Hospital(R&R), New Delhi, India

Shekhar Kansara, Narendra Kotwal, K. V. S. Hari Kumar, Yashpal Singh, Vimal Upreti, Amit Nachankar.

© 2016 Copyright - 日龍儀器股份有限公司